|
| 36416495 | Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma. | Neuro Oncol | 2023 |
| 37118754 | Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas. | J Transl Med | 2023 |
| 37264082 | Editorial Expression of Concern: SIRPa1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration. | Oncogene | 2023 |
| 37129737 | Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model. | J Neurooncol | 2023 |
| 36549916 | Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PET. | J Nucl Med | 2023 |
| 36765908 | MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas. | Cancers (Basel) | 2023 |
| 34813961 | Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase. | Mol Ther | 2022 |
| 35551405 | Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study. | Neuro Oncol | 2022 |
| 35507919 | Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes. | Cancer Immunol Res | 2022 |
| 35610333 | Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma. | Sci Rep | 2022 |
| 35603165 | PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response. | Front Immunol | 2022 |
| 35570396 | Locally secreted BiTEs complement CAR TÂ cells by enhancing killing of antigen heterogeneous solid tumors. | Mol Ther | 2022 |
| 36458202 | The IAP antagonist birinapant enhances chimeric antigen receptor TÂ cell therapy for glioblastoma by overcoming antigen heterogeneity. | Mol Ther Oncolytics | 2022 |
| 35906241 | The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics. | Sci Data | 2022 |
| 36125064 | EGFR, the Lazarus target for precision oncology in glioblastoma. | Neuro Oncol | 2022 |
| 35043276 | MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma. | J Neurooncol | 2022 |
| 35247893 | Glioblastoma: The Current State of Biology and Therapeutic Strategies. | Cancer Res | 2022 |
| 33383491 | Pathology of macrophage activation syndrome in humanized NSGS mice. | Res Vet Sci | 2021 |
| 33521638 | Multi-institutional noninvasive in vivo characterization of <i>IDH</i>, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk). | Neurooncol Adv | 2021 |
| 33781506 | CAR T Cells. | Neurosurg Clin N Am | 2021 |
| 33615225 | Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma. | Neurooncol Adv | 2021 |
| 35121889 | Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma. | Nat Cancer | 2021 |
| 34823154 | Resecting the dominant lesion: Patient outcomes after surgery and radiosurgery vs stand-alone radiosurgery in the setting of multiple brain metastases. | Clin Neurol Neurosurg | 2021 |
| 34568006 | High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms. | Front Oncol | 2021 |
| 34294864 | Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging. | Sci Rep | 2021 |
| 34123793 | Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy. | Front Oncol | 2021 |
| 34026647 | Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma. | Front Oncol | 2021 |
| 31629009 | Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions. | Pharmacol Ther | 2020 |
| 32001402 | Type V Dural Arteriovenous Fistula Supplied by the Artery of Wollschlaeger and Wollschlaeger Causing Cervical Myelopathy and Quadriparesis. | World Neurosurg | 2020 |
| 31666247 | Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study. | Clin Cancer Res | 2020 |
| 31916100 | Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy. | CNS Drugs | 2020 |
| 32102932 | Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. | Sci Transl Med | 2020 |
| 33099328 | An additive score optimized by a genetic learning algorithm predicts readmission risk after glioblastoma resection. | J Clin Neurosci | 2020 |
| 32690110 | A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features. | Acta Neuropathol Commun | 2020 |
| 32152622 | AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium. | Neuro Oncol | 2020 |
| 32271286 | Immunotherapy and Response Assessment in Malignant Glioma: Neuro-oncology Perspective. | Top Magn Reson Imaging | 2020 |
| 32140683 | Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma. | Neurooncol Adv | 2020 |
| 32129893 | Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma. | Cancer | 2020 |
| 32191542 | Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma. | JCO Clin Cancer Inform | 2020 |
| 29676844 | Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI. | J Magn Reson Imaging | 2019 |
| 31815646 | Immune landscapes associated with different glioblastoma molecular subtypes. | Acta Neuropathol Commun | 2019 |
| 31807732 | Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues. | Neurooncol Adv | 2019 |
| 31920606 | Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of <i>de novo</i> Glioblastoma Patients. | Front Comput Neurosci | 2019 |
| 31769726 | Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastoma. | CNS Oncol | 2019 |
| 31217496 | Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma. | Sci Rep | 2019 |
| 31320597 | A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma. | Clin Cancer Res | 2019 |
| 31206012 | Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma. | Acad Pathol | 2019 |
| 31542863 | Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma. | J Neurooncol | 2019 |
| 31218139 | Evaluating the Association Between the Extent of Resection and Survival in Gliosarcoma. | Cureus | 2019 |
| 30926557 | LACE+ Index as Predictor of 30-Day Readmission in Brain Tumor Population. | World Neurosurg | 2019 |